The legal world is bracing for continued turbulence as a shooting incident, a landmark antitrust verdict, and a significant AI acquisition set the stage for next week's developments. Expect heightened security discussions, intensified antitrust scrutiny of AI deals, and a renewed focus on 'pay-for-delay' and trade secret litigation strategies.
Your AI morning briefing for May 20, 2026 — the top stories you need to know.
The way we describe technology in patents is changing, and it's not just academic. New data tracks a seismic shift in legal phrasing, driven by a single court case, with implications for how innovations are protected.
The courtroom drama surrounding Elon Musk's lawsuit against OpenAI's founders is over, and the verdict is clear: Musk's case was built on shaky ground. But beneath the legal wrangling, a far more fascinating narrative about the birth of a technological revolution began to unfold.
The Federal Circuit just tossed out a lower court's dismissal of Medtronic's patent claims. This isn't just legal jargon; it means the fight over kidney denervation tech is back on, and it signals a shift in how patent rights are viewed after licensing deals.
Elon Musk lost his case against OpenAI. AI reporter Michelle Kim joins editor in chief Mat Honan to dissect the trial's implications for the future of artificial intelligence.
Elon Musk's legal battle with OpenAI is over, but the real story is how these AI titans are shaping our future – from the battlefield to your daily tech. Don't get lost in the PR; here's what's actually happening.
Patent infringement litigation just got a jolt of clarity from the CAFC. For years, the court’s stance on standing felt like navigating a foggy maze; now, there’s a clearer path, potentially breathing new life into dismissed cases.
Major tech players are once again under fire for privacy concerns. The Electronic Frontier Foundation is sounding the alarm on Meta, Google, and Palantir, highlighting specific instances of alleged user trust erosion.
We were told AI would be the silver bullet for healthcare's woes, boosting efficiency and accuracy. But is the reality matching the breathless predictions, or are we walking into a minefield?
America's new 'Take It Down Act' promises swift removal of nonconsensual intimate imagery. But lurking beneath the surface are serious concerns about potential misuse and effectiveness.
A prosecutor who quit over alleged political pressure is now running for Congress. Can one person truly fix what ails Washington?
Elon Musk's legal battle against Sam Altman and OpenAI has concluded with a decisive jury verdict. The courtroom drama, which captivated the tech world, saw all charges dismissed.
